Danaos Corporation (the "Company" or "Danaos") (NYSE: DAC) today announced it has received written notice from the New York Stock Exchange (the "NYSE") that the Company is not in compliance with the NYSE
continued listing standard with respect to the minimum average share price required by the NYSE because the average closing price of its common stock had fallen below $1.00 per share over a period of 30 consecutive trading days.
Under the NYSE rules, the Company can regain compliance with this standard and cure this deficiency if, during the six-month period following receipt of the NYSE notice, on the last trading day of any calendar month or on the last trading day of this six-month cure period, the Company's common stock has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30-trading day period ending on the last trading day of that month or the last trading day of the cure period. If the Company determines to remedy the non-compliance by taking action that will require shareholder approval, the Company may obtain shareholder approval by no later than its next annual meeting, and implement such action promptly thereafter. The Company will respond to the NYSE to confirm its intent to cure this noncompliance.
During this period, the Company's common stock will continue to be traded on the NYSE, subject to the Company's compliance with other applicable NYSE listing requirements. The notice does not affect the Company's ongoing business operations or its U.S. Securities and Exchange Commission reporting obligations.